• KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

News

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

All news.
29-04-2024
Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in the United States
Distribution resumes of first and only medicine to treatplasminogen deficiency type 1
Read all
24-04-2024
Kedrion Presents Advancements in Ultra-Rare Bleeding Disorders Research
At World Federation of Hemophilia Congress
Read all
12-07-2023
KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB®
Since 2018 Kedrion has had exclusive distribution rights in the US for KEDRAB®
Read all
Pharmacovigilange
Medical & Scientific Information
2021 Annual report